Mark K Oki - Net Worth and Insider Trading
Mark K Oki Net Worth
The estimated net worth of Mark K Oki is at least $16,469 dollars as of 2024-12-01. Mark K Oki is the CFO of Aytu BioPharma Inc and owns about 9,500 shares of Aytu BioPharma Inc (AYTU) stock worth over $15,295. Mark K Oki is also the CFO & CAO of VIVUS Inc and owns about 10,000 shares of VIVUS Inc (VVUSQ) stock worth over $1,174. Details can be seen in Mark K Oki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark K Oki has not made any transactions after 2022-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark K Oki
Mark K Oki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark K Oki owns 3 companies in total, including VIVUS Inc (VVUSQ) , Alexza Pharmaceuticals Inc (ALXA) , and Aytu BioPharma Inc (AYTU) .
Click here to see the complete history of Mark K Oki’s form 4 insider trades.
Insider Ownership Summary of Mark K Oki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VVUSQ | VIVUS Inc | 2020-01-29 | Chief Financial Officer & CAO |
| ALXA | Alexza Pharmaceuticals Inc | 2015-10-16 | Former SVP & CFO & Secretary |
| AYTU | Aytu BioPharma Inc | 2023-08-11 | Chief Financial Officer |
Mark K Oki Latest Holdings Summary
Mark K Oki currently owns a total of 2 stocks. Among these stocks, Mark K Oki owns 9,500 shares of Aytu BioPharma Inc (AYTU) as of November 18, 2022, with a value of $15,295 and a weighting of 92.87%. Mark K Oki also owns 10,000 shares of VIVUS Inc (VVUSQ) as of November 6, 2018, with a value of $1,174 and a weighting of 7.13%.
Latest Holdings of Mark K Oki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AYTU | Aytu BioPharma Inc | 2022-11-18 | 9,500 | 1.61 | 15,295 |
| VVUSQ | VIVUS Inc | 2018-11-06 | 10,000 | 0.12 | 1,174 |
Holding Weightings of Mark K Oki
Mark K Oki Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark K Oki has made a total of 1 transactions in Aytu BioPharma Inc (AYTU) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aytu BioPharma Inc is the acquisition of 4,500 shares on November 18, 2022, which cost Mark K Oki around $20,700.
According to the SEC Form 4 filings, Mark K Oki has made a total of 0 transactions in VIVUS Inc (VVUSQ) over the past 5 years. The most-recent trade in VIVUS Inc is the acquisition of 10,000 shares on November 6, 2018, which cost Mark K Oki around $40,700.
Insider Trading History of Mark K Oki
- 1
Mark K Oki Trading Performance
GuruFocus tracks the stock performance after each of Mark K Oki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark K Oki is -2.11%. GuruFocus also compares Mark K Oki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark K Oki within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark K Oki's insider trading performs compared to the benchmark.
Performance of Mark K Oki
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.1 | | | | | |
| Relative Return to S&P 500(%) | -19.6 | | | | | |
Mark K Oki Ownership Network
Mark K Oki Owned Company Details
What does VIVUS Inc do?
Who are the key executives at VIVUS Inc?
Mark K Oki is the Chief Financial Officer & CAO of VIVUS Inc. Other key executives at VIVUS Inc include director & Chief Executive Officer John P. Amos , Chief Medical Officer Santosh T Varghese , and SVP & Business Development & GC John L Slebir .
VIVUS Inc (VVUSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VIVUS Inc (VVUSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIVUS Inc (VVUSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VIVUS Inc (VVUSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
VIVUS Inc Insider Transactions
Mark K Oki Mailing Address
Above is the net worth, insider trading, and ownership report for Mark K Oki. You might contact Mark K Oki via mailing address: C/o Alexza Pharmaceuticals Inc, 2091 Stierlin Court, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
